2 stories mentioning NSE:JAGSNPHARMUpdated 42d ago
Every FINWIRES story that references NSE:JAGSNPHARM, newest first.
Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM, BOM:507789) has fixed May 8 as the opening date and May 14 as the closing date for its share buyback plan worth 400 million, according to a Wednesday filing on Indian bourses.Shares of the company rose nearly 2% in Thursday's trade.The company will buy back up to 1.6 million equity shares at 250 rupees per share through the tender offer route, the filing said.
Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM, BOM:507789) net profit jumped to 87.6 million Indian rupees in the fiscal fourth quarter from 65.8 million rupees a year ago, according to a Monday filing with the Indian exchanges.Earnings per share for the quarter ended March 31 climbed to 1.21 rupees from 0.98 rupees a year earlier.Revenue from operations jumped year on year to 642.0 million rupees from 585.6 million rupees, according to the filing.The board of the company declared a dividend of 4 rupees per share for the fiscal year ended March 31.
